EUVIMEDEUVIMED entdecken
Open Access

Alpha-2-Macroglobulin Is a Novel Anticancer Agent

Francesco Facchiano, Daniela D'Arcangelo, Antonio Facchiano

Oncology · 2024

DOI: 10.1159/000536033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Francesco Facchiano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. Hauptthemen laut MEDLINE: Antineoplastic Agents, Melanoma. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Melanoma is the most aggressive skin cancer, with an increasing occurrence. Despite the recent important improvements due to novel immunotherapy approaches, when late diagnosed, melanoma prognosis is poor due to the metastatic progression and drug-resistance onset. Therefore, there is an urgent need to identify additional therapeutic targets. Melanoma invasive behavior is related to the activity of metalloproteases, able to degrade extracellular matrix leading to tumor dissemination. A recent study suggested that the most potent proteases inhibitor alpha-2-macroglobulin (A2MG) from plasma of hibernating fishes exerts potent antiproliferative effects. Our previous studies showed a significant reduction of A2MG in sera from mice/human melanoma models.

Methods

Gene and protein expression studies have been performed by using platforms and databases available online containing expression data from thousands of patients and healthy controls.

Results

We carried out an extensive bioinformatics analysis to evaluate the A2MG gene/protein expression on a large cohort of patients affected by many different cancer types, compared to healthy control subjects, and we found a highly significant difference of A2MG expression in 20 out of 31 cancer types (including melanoma) compared to healthy controls. Similar results were also confirmed at the proteomic level using another platform available online. Further, we found that higher A2MG expression is significantly related to overall survival in different cancers including melanoma.

Conclusion

Our results strongly suggest A2MG as a novel molecular target in melanoma therapy, as well as in other cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMelanomaAnimalsFemaleHumansMicealpha-MacroglobulinsComputational BiologyGene Expression Regulation, NeoplasticNeoplasmsPregnancy-Associated alpha 2-MacroglobulinsProteomicsSkin Neoplasms

Stichwörter der Autor:innen

Alpha-2-macroglobulinAntitumorBiomarkerMelanomaProteases

Substanzen

alpha-MacroglobulinsAntineoplastic AgentsPregnancy-Associated alpha 2-MacroglobulinsA2M protein, human

Autor:innen und Institutionen

  • Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
  • Istituto Dermopatico dell'Immacolata, IDI-IRCCS, FLMM, Rome, Italy.

Zitieren

APA

Facchiano, F., D'Arcangelo, D., & Facchiano, A. (2024). Alpha-2-Macroglobulin Is a Novel Anticancer Agent. Oncology. https://doi.org/10.1159/000536033

Vancouver

Facchiano F, D'Arcangelo D, Facchiano A. Alpha-2-Macroglobulin Is a Novel Anticancer Agent. Oncology. 2024. doi:10.1159/000536033

BibTeX
@article{Facchiano2024,
  author = {Facchiano, Francesco and D'Arcangelo, Daniela and Facchiano, Antonio},
  title = {Alpha-2-Macroglobulin Is a Novel Anticancer Agent},
  journal = {Oncology},
  year = {2024},
  doi = {10.1159/000536033}
}
Kostenlos starten →